Blocking of MEK and mTORC1/2 at the same time, using trametinib and sapanisertib leads to apoptosis and reduction of canine MM cells survival, although these results have not been confirmed on human MMs.18 This evidence concerns the gene MAP2K7 and Miyoshi myopathy.